Healx
Updates & Highlights
cambridgeindependent.co.uk · about 2 months ago
First patient is dosed in Healx HLX-4310 trial backed by Sunshine Project consortium
Yahoo Finance · about 2 months ago
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
Business Weekly · about 2 months ago
Healx reveals first patient dosing in fight against rare bone cancer
Recent Openings
View all 1 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Parental Leave
Family-friendly policies
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Healx?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentFirst patient is dosed in Healx HLX-4310 trial backed by Sunshine Project consortium
First patient is dosed in Healx HLX-4310 trial backed by Sunshine Project consortium
cambridgeindependent.co.uk · about 2 months ago
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
Yahoo Finance · about 2 months ago
Healx reveals first patient dosing in fight against rare bone cancer
Healx reveals first patient dosing in fight against rare bone cancer
Business Weekly · about 2 months ago
Healx Announces First Patient Dosed in Phase 1/2 Trial to
Healx Announces First Patient Dosed in Phase 1/2 Trial to
GlobeNewswire · about 2 months ago
Healx Doses First Patient in HLX-4310 Trial for Metastatic Osteosarcoma
Healx Doses First Patient in HLX-4310 Trial for Metastatic Osteosarcoma
The Clinical Trial Vanguard · about 2 months ago
CAN Community Health Launches Healx Solutions to Expand Access in Specialty Therapy Services
CAN Community Health Launches Healx Solutions to Expand Access in Specialty Therapy Services
Business Wire · 4 months ago
Healx AI: 10 Essential Facts About the Cambridge Rare Disease Drug Discovery Pioneer
Healx AI: 10 Essential Facts About the Cambridge Rare Disease Drug Discovery Pioneer
International Business Times Australia · 5 months ago
Artificial Intelligence Biotechnology Market Next Big Thing | Major Giants Healx, Cyclica, Iktos
Artificial Intelligence Biotechnology Market Next Big Thing | Major Giants Healx, Cyclica, Iktos
openPR.com · 6 months ago
Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
01net · 12 months ago
Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
Yahoo Finance · 12 months ago
Healx AI alliance with US-based Vuja De Sciences targets killer cancer recurrence
Healx AI alliance with US-based Vuja De Sciences targets killer cancer recurrence
Business Weekly · 12 months ago
Healx and SCI Ventures partner to help treat paralysis using AI
Healx and SCI Ventures partner to help treat paralysis using AI
Home | Digital Health · about 1 year ago
Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
Cambridge Network · about 1 year ago
Healx secures $2m from SCI Ventures for neurotrauma focus
Healx secures $2m from SCI Ventures for neurotrauma focus
Cambridge Independent · about 1 year ago
Healx and SCI Ventures Partner to Uncover Cures for Paralysis with AI-Driven Drug Discovery
Healx and SCI Ventures Partner to Uncover Cures for Paralysis with AI-Driven Drug Discovery
Genetic Engineering and Biotechnology News · about 1 year ago
$40m 'Superman' backed fund partners with Healx to fight paralysis
$40m 'Superman' backed fund partners with Healx to fight paralysis
Business Weekly · about 1 year ago
Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial
Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial
Clinical Trials Arena · over 1 year ago
Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options
Healx Candidate, SpringWorks Therapy Expand NF1 Treatment Options
Genetic Engineering and Biotechnology News · over 1 year ago
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
BioSpace · over 1 year ago
History beckons as Healx doses first rare cancer patient with AI-created drug
History beckons as Healx doses first rare cancer patient with AI-created drug
Business Weekly · over 1 year ago